Evaluation of NETosis Inhibitors in a Laboratory-Developed ex-vivo Human Neutrophil Model

Journal of Inflammation Research 2026 Open access

Read full text
Authors: Constant Gillot, Pauline Michaux, Jonathan Decarpentrie, Romane Vandamme, Jean‐Michel Dogné, Julien Favresse, Jonathan Douxfils
DOI: 10.2147/jir.s571649
Cited by: 0
References: 6

Abstract

Constant Gillot,1 Pauline Michaux,1 Jonathan Decarpentrie,1 Romane Vandamme,1 Jean-Michel Dogné,1 Julien Favresse,1,2 Jonathan Douxfils1,3 1Clinical Pharmacology and Toxicology Research Unit, Namur Research Institute for Life Sciences, University of Namur, Namur, 5000, Belgium; 2Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, 5000, Belgium; 3Qualiblood s.a., Research and Development Department, Liège, 4000, BelgiumCorrespondence: Constant Gillot, Email constant.gillot@unamur.be

Fields of Study & Subjects

Neutrophil Myeloperoxidase and Oxidative Mechanisms Inflammation biomarkers and pathways Coagulation Bradykinin Polyphosphates and Angioedema

Publication details

Journal / source
Journal of Inflammation Research
Volume
Volume 19
Pages
1–5
Publication date
1 January 2026
Language
EN